Compare IRMD & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRMD | BCX |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 930.9M |
| IPO Year | 2014 | N/A |
| Metric | IRMD | BCX |
|---|---|---|
| Price | $81.28 | $10.59 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $118.00 | N/A |
| AVG Volume (30 Days) | 91.1K | ★ 154.5K |
| Earning Date | 10-30-2026 | 01-01-0001 |
| Dividend Yield | 0.97% | ★ 6.99% |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $83,814,000.00 | N/A |
| Revenue This Year | $9.69 | N/A |
| Revenue Next Year | $11.28 | N/A |
| P/E Ratio | $60.41 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $76.35 | $9.71 |
| 52 Week High | $107.90 | $13.86 |
| Indicator | IRMD | BCX |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 21.04 |
| Support Level | $76.65 | N/A |
| Resistance Level | $89.25 | $12.05 |
| Average True Range (ATR) | 2.88 | 0.27 |
| MACD | -0.33 | -0.12 |
| Stochastic Oscillator | 27.73 | 0.96 |
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies, or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.